Finance

Beta
Lists
TCRX:NASDAQ
Tscan Therapeutics Inc
$1.02
+2.55%
(+0.025) 1D
$1.02
0.00% (0.00)
After hours
Closed: May 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TCRX...
Open
$0.99
High
$1.04
Low
$0.98
Mkt. cap
66.97M
Avg. vol.
1.15M
Volume
224.23K
52-wk high
$2.57
52-wk low
$0.88
EPS
-$0.96
Beta
1.07
Shares outstanding
61.07M
No. of employees
138
News stories
From sources across the web
About Tscan Therapeutics Inc
CEO-
Employees138
Founded2018
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitetscan.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.08M
2.51M
2.57M
982.00K
Cost of goods sold
32.63M
31.69M
18.44M
21.90M
Cost of revenue
32.63M
31.69M
18.44M
21.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.10M
7.87M
5.99M
8.22M
Operating expense
9.10M
7.87M
5.99M
8.22M
Total operating expenses
41.73M
39.56M
24.42M
30.12M
Operating income
-38.65M
-37.05M
-21.86M
-29.14M
Other non operating income
-
-
-
-
EBT including unusual items
-36.95M
-35.71M
-22.98M
-28.67M
EBT excluding unusual items
-36.95M
-35.71M
-20.98M
-28.67M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-36.95M
-35.71M
-22.98M
-28.67M
Net profit margin
-1,201.30%
-1,422.14%
-895.09%
-2,919.14%
Earnings per share
-0.28
-0.28
-0.18
-0.22
Interest and investment income
2.39M
2.04M
1.58M
1.16M
Interest expense
-689.00K
-699.00K
-702.00K
-689.00K
Net interest expenses
1.70M
1.34M
881.00K
473.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-37.96M
-36.28M
-21.14M
-28.45M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer